Villanova, PA, United States of America

Lori Krim Gavrin

USPTO Granted Patents = 10 

 

 

Average Co-Inventor Count = 16.6

ph-index = 3

Forward Citations = 46(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Lori Krim Gavrin: Innovator in Pharmaceutical Compounds

Introduction

Lori Krim Gavrin is a distinguished inventor based in Villanova, PA (US). She has made significant contributions to the field of pharmaceuticals, holding a total of 10 patents. Her work primarily focuses on the development of innovative compounds that have therapeutic applications.

Latest Patents

Among her latest patents are the bicyclic-fused heteroaryl or aryl compounds. These patents disclose compounds, tautomers, and pharmaceutically acceptable salts, characterized by a specific structure defined in the specification. In one embodiment, a pharmaceutical composition can be formulated in a liquid dosage form, containing a therapeutically effective amount of the compound or its pharmaceutically acceptable salt as an adjuvant and therapeutic agent. Additionally, methods for adjuvant treatment of various disorders or conditions are also outlined, which involve administering the pharmaceutical composition to patients.

Career Highlights

Lori has had a notable career, working with prominent organizations such as Pfizer Corporation and the Cystic Fibrosis Foundation. Her experience in these companies has allowed her to contribute to significant advancements in pharmaceutical research and development.

Collaborations

Lori has collaborated with esteemed colleagues, including Joseph Walter Strohbach and Christoph Wolfgang Zapf. These partnerships have further enhanced her innovative work in the pharmaceutical sector.

Conclusion

Lori Krim Gavrin is a remarkable inventor whose contributions to pharmaceutical compounds have the potential to impact patient care significantly. Her dedication to innovation and collaboration continues to drive advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…